Fate Therapeutics Reports Third Quarter 2016 Financial Results

Go back to Fate Therapeutics Reports Third Quarter 2016 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.53 --0 (-0%)
Previous Close $2.53    52 Week High $4.76 
Open $2.53    52 Week Low $1.46 
Day High $2.53    P/E N/A 
Day Low $2.53    EPS $-1.91 
Volume 2,050